相关实验视频
Updated: Jun 11, 2025

06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.4K
今天欧洲的皮肤癌和明天的挑战
Lieve Brochez1,2, Beate Volkmer3, Isabelle Hoorens1,2
1Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
概括
皮肤癌是欧洲的主要健康挑战,紫外线暴露导致黑色素瘤和角质细胞癌 (KC) 的增加. 需要一个欧洲行动计划来减少紫外线暴露,改善早期诊断和治疗.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 公共卫生 公共卫生
背景情况:
- 在全球范围内,皮肤癌占癌症诊断的三分之一.
- 欧洲在紫外线引起的癌症方面处于领先地位,黑色素瘤和角质细胞癌症 (KC) 的发病率很高.
- 预计欧洲的KC发病率 (40%) 和死亡率 (50%) 将会增加.
研究的目的:
- 为了突出欧洲日益增长的皮肤癌负担.
- 为了确定皮肤癌率上升的关键驱动因素.
- 倡导欧洲皮肤癌行动计划.
主要方法:
- 对欧洲当前皮肤癌统计数据的分析.
- 确定主要的风险因素,包括紫外线暴露和人口老龄化.
- 预测皮肤癌发病率和死亡率的未来趋势.
主要成果:
- 欧洲面临着严重且日益增加的皮肤癌负担.
- 紫外线 (UV) 辐射是这种流行病的主要驱动因素.
- 预计男性的状细胞癌 (KC) 死亡率将接近女性的黑色素瘤死亡率.
结论:
- 皮肤癌对欧洲的医疗保健构成了重大,不断升级的挑战.
- 一个全面的欧洲皮肤癌行动计划是必要的.
- 该计划应侧重于减少紫外线暴露,并加强早期检测和治疗策略.
相关概念视频
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Changes in Skin Color: Clinical Perspectives
1.8K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
1.8K
Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329

